Publication:
Assessment of diagnostic value of HLA-DQ2/DQ8 typing and anti-tissue transglutaminase antibodies as an alternative to duodenal biopsy in pediatric celiac disease

dc.contributor.authorProkić, Dragan (6603769235)
dc.contributor.authorĐuričić, Slaviša (22940480000)
dc.contributor.authorKitić, Ivana (56079613400)
dc.contributor.authorKocić, Marija (57192209334)
dc.contributor.authorPašić, Srđan (55904557400)
dc.contributor.authorVuletić, Biljana (25121846900)
dc.date.accessioned2025-06-12T12:23:29Z
dc.date.available2025-06-12T12:23:29Z
dc.date.issued2023
dc.description.abstractIntroduction/Objective The objective of the paper is to assess the applicability of serum anti-tissue transglutaminase (tTG) antibodies IgA and IgG concentration and HLA-DQ2/DQ8 typing as a non-invasive alternative to duodenal biopsy in diagnosing celiac disease (CD) in pediatric population. Methods A prospective cohort study included a total of 179 pediatric patients aged 1–18 years. Determination of tTG IgA and tTG IgG antibodies and human leukocyte antigen (HLA) DQ2/DQ8 typing was performed for all patients. Histology of duodenal biopsies was interpreted by the modified Marsh scoring system. Results The diagnosis of CD was confirmed in 101 (56%) patients of the studied population. In cases of CD, HLA-DQ2/DQ8 was positive in 100 patients (99%). The tTG IgA antibodies in concentration higher than 100 U/ml were detected in 77 (76.2%) of the CD patients and in significantly smaller number for tTG IgG [29 (28.7%)] (p < 0.001). Statistically highly significant association of duodenal lesions Marsh grade 3 with concentration of tTG IgA 10-fold higher than the upper level of normal (ULN) was established (p < 0.001) Conclusion Concentration of tTG IgA 10-fold higher than ULN is significantly positively correlated with Marsh grade 3 histopathology findings. Specific antibodies determination in combination with HLA-DQ2/ DQ8 typing proves to be sufficient for a diagnosis of CD, supporting the fact that duodenal biopsy may be avoided in a significant majority of patients – 75%. © 2023, Serbia Medical Society. All rights reserved.
dc.identifier.urihttps://doi.org/10.2298/SARH230113064P
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85175199948&doi=10.2298%2fSARH230113064P&partnerID=40&md5=487d4ee4cc19858ccad8c74430c97262
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/2967
dc.subjectceliac disease
dc.subjectHLA-DQ2/DQ8 typing
dc.subjectnon-invasive
dc.subjecttissue transglutaminase antibodies
dc.titleAssessment of diagnostic value of HLA-DQ2/DQ8 typing and anti-tissue transglutaminase antibodies as an alternative to duodenal biopsy in pediatric celiac disease
dspace.entity.typePublication

Files